INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 29 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $414,000 | +43.8% | 1,460,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $288,000 | -60.5% | 1,460,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $730,000 | -31.4% | 1,460,000 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $1,064,000 | -85.6% | 1,460,000 | -14.1% | 0.00% | -83.3% |
| Q2 2019 | $7,378,000 | -40.8% | 1,700,000 | 0.0% | 0.02% | -41.9% |
| Q1 2019 | $12,461,000 | -2.8% | 1,700,000 | 0.0% | 0.03% | -13.9% |
| Q4 2018 | $12,818,000 | +12.0% | 1,700,000 | -16.0% | 0.04% | +38.5% |
| Q3 2018 | $11,441,000 | +28.4% | 2,025,000 | 0.0% | 0.03% | +30.0% |
| Q2 2018 | $8,910,000 | -18.3% | 2,025,000 | +17.4% | 0.02% | -20.0% |
| Q1 2018 | $10,911,000 | +22.8% | 1,725,000 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $8,884,000 | -42.5% | 1,725,000 | 0.0% | 0.02% | -47.4% |
| Q3 2017 | $15,439,000 | – | 1,725,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
| ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
| DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
| MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
| Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
| Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
| CAXTON CORP | 64,817 | $285,000 | 0.10% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
| 683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |